ZHU:CA:TSX-BMO Equal Weight US Health Care (CAD)

COMMON STOCK | |

Last Closing

CAD 43.08

Change

0.00 (0.00)%

Market Cap

CAD 0.05B

Volume

1.70K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-15 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
TD-PFD:CA Toronto Dominion Bank Pref D

N/A

CAD 170.62B
TD-PFI:CA Toronto-Dominion Bank Pref Ser..

+0.05 (+0.19%)

CAD 163.85B
ENB-PFV:CA Enbridge Inc Pref 5

+0.09 (+0.38%)

CAD 120.95B
ENB-PFA:CA Enbridge Inc Pref 9

+0.08 (+0.42%)

CAD 116.37B
ENB-PFC:CA Enbridge Inc Pref 11

+0.06 (+0.33%)

CAD 109.42B
ENB-PFG:CA Enbridge Inc Pref 15

-0.01 (-0.06%)

CAD 105.94B
ENB-PFU:CA Enbridge Inc Pref L

+0.05 (+0.23%)

CAD 86.59B
PPL-PFA:CA Pembina Pipeline Corp Pref Ser..

+0.05 (+0.22%)

CAD 9.53B
EIT-UN:CA Canoe EIT Income Fund

N/A

CAD 2.67B
EVT:CA Economic Investment Trust Ltd

N/A

CAD 0.93B

ETFs Containing ZHU:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.20% N/A N/A 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.20% N/A N/A 43% F
Trailing 12 Months  
Capital Gain 2.09% N/A N/A 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.09% N/A N/A 31% F
Trailing 5 Years  
Capital Gain 43.84% N/A N/A 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 43.84% N/A N/A 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 7.30% N/A N/A 68% D+
Dividend Return 7.30% N/A N/A 62% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.24% N/A N/A 59% D-
Risk Adjusted Return 55.15% N/A N/A 79% B-
Market Capitalization 0.05B N/A N/A 27% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike